Use of Imaging Systems in Gynecologic Cytology
Angelique W. Levi, MD
Presentation date: June 28, 2011; Expiration date: June 28, 2014
One-third of cervical cytology false-negatives are caused by screening and interpretive errors in which abnormal cells are incorrectly classified. Automated screening instruments address these key sources of error and cost. FDA-approved imaging systems will be reviewed with a brief history of cytology automation, and the Yale experience will be discussed.